GB Sciences Signs Consulting Services Agreement with Worldwide Clinical Trials, Inc.

Article

Applied Clinical Trials

GB Sciences, Inc. announced it has signed a consulting services agreement with Worldwide Clinical Trials, Inc. to assess the company's intellectual property portfolio and help with pre-IND planning for its cannabis-based formulations. Pre-IND consulting services will be performed by Michael F. Murphy, MD, PhD, chief medical and scientific officer (CMSO) of Worldwide Clinical Trials, Inc.

Read the full release here

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.